NorDiag ASA

https://www.nordiag.com

NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 35.3 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD. *

	Group	NorDiag (Group)
	Industry	molecular diagnostics
	Industry 2	diagnostic test, cancer

	Region	Oslo
	Country	Norway
	Street	40 Frysjaveien
	City	0884 Oslo
	Tel	+47-22-026565
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2008-10-30)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)